Table 1 Baseline characteristics of the cohort
Parameter | Total | Private practice | Hospital-based units | P value |
|---|---|---|---|---|
Population (n) | 1,591 | 492 | 1,099 | - |
Gender (%) | <0.001 | |||
Male | 80.0 | 87.0 | 76.9 | |
Female | 20.0 | 13.0 | 23.1 | |
Age (years) (median, range) | 38 (18 to 78) | 38 (19 to 69) | 38 (18 to 78) | 0.1 |
Nationality (%) | <0.001 (German versus others) | |||
German | 71.9 | 81.3 | 67.7 | |
Thai | 2.4 | 0.8 | 3.1 | |
Turkish | 2.3 | 2.0 | 2.5 | |
Cameroonian | 2.2 | 0.4 | 3.0 | |
Kenyan | 2.2 | 1.8 | 2.4 | |
Other (<2%) | 18.6 | 13.3 | 20.9 | |
Missing data | 0.4 | 0.4 | 0.4 | |
Ethnic origin (%) | <0.001 (Caucasian versus others) | |||
Caucasian | 81.2 | 89.0 | 77.7 | |
African | 13.3 | 7.7 | 15.7 | |
Asian | 3.5 | 1.0 | 4.6 | |
Other (<1%) | 1.6 | 1.7 | 1.7 | |
Missing data | 0.4 | 0.6 | 0.3 | |
HIV transmission groups (%) | <0.001 (MSM versus others) | |||
MSM | 52.5 | 68.3 | 45.5 | |
Heterosexual | 18.7 | 12.2 | 21.7 | |
Endemic region | 14.6 | 7.3 | 17.9 | |
Intravenous drug abuse | 5.7 | 5.3 | 5.9 | |
Others (<1%) | 1.6 | 0.4 | 2.0 | |
Missing data | 6.9 | 6.5 | 7.0 | |
Duration of HIV-positivity (months) (median, range) | 1 (0 to 260) | 5 (0 to 260) | 1 (0 to 244) | <0.001 |
CDC stage (%) | 0.042 (AIDS versus non-AIDS) | |||
A | 39.7 | 46.0 | 37.2 | |
B | 26.9 | 26.5 | 27.1 | |
C | 33.4 | 27.5 | 35.7 | |
CD4 cell count (CD4 cells/μL) (median, range) | 210 (0 to 1,224) | 246.5 (0 to 1,224) | 189.5 (1 to 1,014) | <0.001 |
Viral load (copies/mL) (median, range) | 75,345.5 (227 to 5,022,690) | 100,000 (227 to 5,022,690) | 68,828 (508 to 500,000) | 0.041 |
HIV-1 subtype: B | 71.9 | 81.3 | 67.7 | <0.001 (B versus others) |
Transmitted drug resistance: resistance demonstrated | 9.7 | 10.8 | 9.2 | 0.36 (resistance versus wild type) |